Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2085

1.

[Study on key techniques and intervention in reducing birth defects].

Zhu BS, Su J, Lu XH, He J, Zhu S, Jiao CX, Zhang JM, Tang XH, Tao Y, Lin KP, Chen H, Li SY.

Zhonghua Fu Chan Ke Za Zhi. 2011 Sep;46(9):658-63. Chinese.

PMID:
22176989
2.

Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.

Audibert F, Gagnon A; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada.; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists..

J Obstet Gynaecol Can. 2011 Jul;33(7):754-67.

PMID:
21749753
3.

'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.

Zanini R, Tarantini M, Cerri V, Jacobello C, Bellotti D, Lancetti S, Scalchi S, Groli C, Bianchi UA.

Fetal Diagn Ther. 1998 Mar-Apr;13(2):106-10.

PMID:
9650657
5.

[Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].

Hu YL; Birth Defect Intervention Group of Jiangsu Province..

Zhonghua Yi Xue Za Zhi. 2007 Sep 18;87(35):2476-80. Chinese.

PMID:
18067809
6.
7.

[A study on gene mutation spectrums of α- and β-thalassemias in populations of Yunnan Province and the prenatal gene diagnosis].

Zhu BS, He J, Zhang J, Zeng XH, Su J, Xu XH, Li SY, Chen H, Zhang YH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Feb;47(2):85-9. Chinese.

PMID:
22455737
8.

[Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].

Hu Z, Liu X, Li L, Jia C, Li D, Liu R.

Zhonghua Fu Chan Ke Za Zhi. 2014 Oct;49(10):749-53. Chinese.

PMID:
25537246
9.

[Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].

Wang SJ, Gao ZY, Lu YP, Li YL, You YQ, Zhang LW, Wang LX, Xu H.

Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):808-12. Chinese.

PMID:
23302119
10.

The use of folic acid for the prevention of neural tube defects and other congenital anomalies.

Wilson RD, Davies G, Désilets V, Reid GJ, Summers A, Wyatt P, Young D; Genetics Committee and Executive and Council of the Society of Obstetricians and Gynaecologists of Canada..

J Obstet Gynaecol Can. 2003 Nov;25(11):959-73. Review.

PMID:
14608448
11.

[Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].

Hou QF, Wu D, Chu Y, Kang B, Liao SX, Yang YL, Zhang CY, Zhang JX, Wu G.

Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):813-7. Chinese.

PMID:
23302120
12.

Prenatal genetic screening for Down syndrome and open neural tube defects using maternal serum markers in Thai pregnant women.

Wasant P, Liammongkolkul S.

Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:244-8.

PMID:
15906746
13.

Maternal serum second trimester screening for chromosomal disorders and neural tube defects in a government hospital of North India.

Kaur G, Srivastav J, Kaur A, Huria A, Goel P, Kaur R, Kataria S, Chavan BS, Kochhar S, Aggarwal P, Kaur N, Panigrahi I, Chawla P.

Prenat Diagn. 2012 Dec;32(12):1192-6. doi: 10.1002/pd.3984. Epub 2012 Oct 11.

PMID:
23055346
14.
15.

[Maternal serum screening for Down syndrome and neural tube defects].

van Rijn M, Christiaens GC, van der Schouw YT, Hagenaars AM, de Pater JM, Visser GH.

Ned Tijdschr Geneeskd. 1998 Feb 21;142(8):409-15. Dutch.

PMID:
9562776
16.

[Folate consumption in the preconception period of Sicilian pregnant women and their knowledge about the prevention of neural tube defect by folate supplementation].

Pepe F, Pepe P, Montaperto A, Rotolo N, Florio ML, Uccellatore F.

Minerva Ginecol. 1999 May;51(5):177-81. Italian.

PMID:
10431526
17.

MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study.

Jørgensen FS, Valentin L, Salvesen KA, Jørgensen C, Jensen FR, Bang J, Eik-Nes SH, Madsen M, Marsal K, Persson PH, Philip J, Bogstad JW, Nørgaard-Pedersen B.

Acta Obstet Gynecol Scand. 1999 Jul;78(6):501-10.

PMID:
10376859
18.

Obstetric, perinatal, and fetal outcomes in pregnancies with false-positive integrated screening results.

Baer RJ, Currier RJ, Norton ME, Flessel MC, Goldman S, Towner D, Jelliffe-Pawlowski LL.

Obstet Gynecol. 2014 Mar;123(3):603-9. doi: 10.1097/AOG.0000000000000145.

PMID:
24499760
19.

Triploidy identified through second-trimester serum screening.

Huang T, Alberman E, Wald N, Summers AM.

Prenat Diagn. 2005 Mar;25(3):229-33.

PMID:
15791661

Supplemental Content

Support Center